Compounds > aldosterone
Page last updated: 2024-08-17

aldosterone and rosiglitazone

aldosterone has been researched along with rosiglitazone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gege, C; Hoffmann, T; Schlüter, T1
Amiri, F; Cohn, JS; Diep, QN; El Mabrouk, M; Endemann, D; Neves, MF; Schiffrin, EL; Virdis, A1
Gonzalez, FJ; Kohan, DE; Nelson, RD; Yang, T; Zhang, A; Zhang, H1
Goenka, N; Kotonya, C; O'Hare, JP; Penney, MD; Randeva, HS1
Akahira, J; Hui, XG; Ito, S; Kudo, M; Matsuda, K; Nakamura, Y; Noguchi, N; Okamoto, H; Rainey, WE; Sasano, H; Satoh, F; Sugawara, A; Uruno, A; Yoshikawa, T1
Chen, R; Ding, G; Huang, S; Yuan, Y; Zhang, A1

Trials

1 trial(s) available for aldosterone and rosiglitazone

ArticleYear
Thiazolidinediones and the renal and hormonal response to water immersion-induced volume expansion in type 2 diabetes mellitus.
    American journal of physiology. Endocrinology and metabolism, 2008, Volume: 294, Issue:4

    Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Diabetes Mellitus, Type 2; Homeostasis; Humans; Hypoglycemic Agents; Immersion; Kidney; Male; Middle Aged; Natriuresis; Renin; Rosiglitazone; Thiazolidinediones; Water-Electrolyte Imbalance

2008

Other Studies

5 other study(ies) available for aldosterone and rosiglitazone

ArticleYear
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.
    Bioorganic & medicinal chemistry letters, 2014, Nov-15, Volume: 24, Issue:22

    Topics: Benzeneacetamides; Drug Inverse Agonism; Fluorescence Resonance Energy Transfer; Humans; Ligands; Nuclear Receptor Subfamily 1, Group F, Member 2; Nuclear Receptor Subfamily 1, Group F, Member 3; Protein Binding; Th17 Cells; Thiazoles; Tretinoin

2014
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
    Circulation, 2002, May-14, Volume: 105, Issue:19

    Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blood Vessels; Body Weight; Cell Cycle Proteins; Cell Division; Collagen; DNA; Drug Administration Schedule; Endothelium, Vascular; In Vitro Techniques; Inflammation; Injections, Subcutaneous; Lipids; Male; NF-kappa B; Pioglitazone; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Renin; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Vascular Cell Adhesion Molecule-1; Vasoconstrictor Agents; Vasodilator Agents

2002
Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Jun-28, Volume: 102, Issue:26

    Topics: Aldosterone; Animals; Biological Transport; Body Weight; Coloring Agents; Diabetes Mellitus, Type 2; Evans Blue; Gene Deletion; Genotype; Heterozygote; Hypoglycemic Agents; Immunohistochemistry; Integrases; Kidney; Kidney Tubules, Collecting; Mice; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Nephrons; PPAR gamma; Promoter Regions, Genetic; Radioimmunoassay; Rosiglitazone; Sodium; Thiazolidinediones

2005
Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production.
    Journal of molecular endocrinology, 2011, Volume: 46, Issue:1

    Topics: Adrenal Cortex; Aldosterone; Benzophenones; Benzylamines; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinase Type 1; Cell Line; Cytochrome P-450 CYP11B2; Gene Expression; Gene Expression Regulation, Enzymologic; Humans; Ionomycin; Mutation; Pioglitazone; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Sulfonamides; Thiazolidinediones; Transcription, Genetic; Tyrosine; Zona Glomerulosa

2011
A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
    American journal of physiology. Renal physiology, 2011, Volume: 300, Issue:2

    Topics: Aldosterone; Animals; Cell Proliferation; Cells, Cultured; Cyclin A; Cyclin D1; ErbB Receptors; Mesangial Cells; Mice; Mineralocorticoid Receptor Antagonists; Nitro Compounds; Phosphatidylinositol 3-Kinases; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones

2011